Biorchestra announces US$45 million series C fundraising

he financing was significantly oversubscribed with high demand from both existing and new investors.

Vicore advances on new chemical entity from VP03 program

Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022

Moderna and Thermo Fisher Scientific to deepen mRNA collaboration

The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Merck completes acquisition of biopharma CDMO Exelead

Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science

Bayer highlights pharma business plans on Media Day

Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)

Abbott's CardioMEMS HF System receives USFDA approval

New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure

PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery

He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,

Prestige BioPharma’s Tuznue receives EU-GMP certification

Thermo Scientific offers a new portfolio of chromatography and mass spectrometry consumables

The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets

World’s first clinical trial for 3D bioprinted stem cell vascular grafts in China

Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.